Patient age and cancer treatment decisions -: Patient and physician views

被引:41
作者
Kutner, JS
Vu, KO
Prindiville, SA
Byers, TE
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Gen Internal Med, Denver, CO 80202 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80202 USA
关键词
cancer; decision making; elderly; patient; physician;
D O I
10.1046/j.1523-5394.2000.83004.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: The purpose of this study was to examine patient and physician factors influencing the decision to use adjuvant chemotherapy for stage III colon cancer in elderly persons. DESCRIPTION or STUDY: A cross-sectional mailed population-based survey of patients 65 years of age and older who had undergone surgical resection of stage III colon cancer in Colorado between august 1995 and December 1997 were identified by the statewide cancer registry (n = 276) and their treating physicians (n = 232). A questionnaire about the determinants of colon cancer treatment decisions was mailed to all patients for whom physician permission was granted (n = 119). A similar questionnaire was sent to treating physicians. RESULTS: Ninety-two physicians (internal medicine 23%; family medicine 12%; surgery 37%; and oncology 24%) and 67 patients (mean age 75.8 years; 55% women) completed surveys. Fifty-four (80.6%) of the patients had received adjuvant chemotherapy. The major determinants of receiving adjuvant chemotherapy were having seen an oncologist (P = .003), being younger (P = .003), and being married (P = .021). After controlling for other potential influences, only having seen an oncologist (odds ratio 8.0; confidence interval 1.5-43.1) remained significantly associated with the receipt of chemotherapy. Physicians were more likely than patients to rank comorbid conditions (39.1% versus 3.0%, respectively; P < .001) and the medical literature (20.7% versus 4.5%, respectively; P = .004) as important factors in making treatment decisions, while patients were more likely than physicians to rank physician opinion (73.1% versus 26.1%, respectively; P = .001), family preference (31.3% versus 9.8%, respectively; P = .001), and family burden (10.4% versus 2.2%, respectively; P = .038). CLINICAL IMPLICATIONS: In this elderly population, patient age is not recognized by patients or physicians as affecting the decision to use adjuvant chemotherapy. Other biologic and social factors are important, however, and the perspectives of physicians and patients differ regarding their relative importance.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 20 条
[11]   Adjuvant therapy for colon cancer [J].
Macdonald, JS .
CA-A CANCER JOURNAL FOR CLINICIANS, 1997, 47 (04) :243-256
[12]   THE INFLUENCE OF TREATMENT DESCRIPTIONS ON ADVANCE MEDICAL DIRECTIVE DECISIONS [J].
MALLOY, TR ;
WIGTON, RS ;
MEESKE, J ;
TAPE, TG .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1992, 40 (12) :1255-1260
[13]   HOW THE MANNER OF PRESENTATION OF DATA INFLUENCES OLDER PATIENTS IN DETERMINING THEIR TREATMENT PREFERENCES [J].
MAZUR, DJ ;
MERZ, JF .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1993, 41 (03) :223-228
[14]   LEVAMISOLE AND FLUOROURACIL FOR ADJUVANT THERAPY OF RESECTED COLON-CARCINOMA [J].
MOERTEL, CG ;
FLEMING, TR ;
MACDONALD, JS ;
HALLER, DG ;
LAURIE, JA ;
GOODMAN, PJ ;
UNGERLEIDER, JS ;
EMERSON, WA ;
TORMEY, DC ;
GLICK, JH ;
VEEDER, MH ;
MAILLIARD, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) :352-358
[15]   FLUOROURACIL PLUS LEVAMISOLE AS EFFECTIVE ADJUVANT THERAPY AFTER RESECTION OF STAGE-III COLON-CARCINOMA - A FINAL REPORT [J].
MOERTEL, CG ;
FLEMING, TR ;
MACDONALD, JS ;
HALLER, DG ;
LAURIE, JA ;
TANGEN, CM ;
UNGERLEIDER, JS ;
EMERSON, WA ;
TORMEY, DC ;
GLICK, JH ;
VEEDER, MH ;
MAILLIARD, JA .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (05) :321-326
[16]   THE INFLUENCE OF THE PROBABILITY OF SURVIVAL ON PATIENTS PREFERENCES REGARDING CARDIOPULMONARY-RESUSCITATION [J].
MURPHY, DJ ;
BURROWS, D ;
SANTILLI, S ;
KEMP, AW ;
TENNER, S ;
KRELING, B ;
TENO, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (08) :545-549
[17]  
RIES LAG, 1997, NIH PUBLICATION
[18]   THE ELDERLY PATIENT AND INFORMED CONSENT - EMPIRICAL-FINDINGS [J].
STANLEY, B ;
GUIDO, J ;
STANLEY, M ;
SHORTELL, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (10) :1302-1306
[19]   ARE WE GETTING INFORMED CONSENT FROM PATIENTS WITH CANCER [J].
SUTHERLAND, HJ ;
LOCKWOOD, GA ;
TILL, JE .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1990, 83 (07) :439-443
[20]  
Ware JE, 1995, SF-12: how to score the SF-12 physical and mental health summary scales